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Diglycidyl ethers of bisphenol A (DGEBA) and bisphenol F (DGEBF) are widely used as 
components in epoxy resin thermosetting products. They are known to cause occupational and 
non-occupational allergic contact dermatitis. The aim of this study is to investigate analogues of 
DGEBF with regard to contact allergy and cytotoxicity. A comprehensive knowledge of the 
structural features that contribute to the allergenic and cytotoxic effects of DGEBF will guide the 
development of future novel epoxy resin systems with reduced health hazards for those coming 
into contact with them. It was found that the allergenic effects of DGEBF were dependent on its 
terminal epoxide groups. In contrast, it was found that the cytotoxicity in monolayer cell culture 
was not only dependent on the presence of epoxide groups, but also on other structural features. 
Abbreviations 
DGEBA Diglycidyl ether of bisphenol A 
DGEBF Diglycidyl ether of bisphenol F 
ERS  Epoxy resin systems 
IARC  International Agency for Research on Cancer 
LLNA  Local lymph node assay 
MTT  3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
N-ACME N-Acetyl-L-cysteine methyl ester 
PGE  Phenyl glycidyl ether 






Epoxy resin systems (ERS) are commercial thermosetting products that are combinations of 
epoxy resins, curing agents, modifiers, and reactive diluents used in applications where strong, 
flexible, and light-weight construction materials are required. The global epoxy resin market is 
projected to reach over 3 million tons in annual sales by 2017.1 Examples of their uses are in 
paints, adhesives, coatings and electrical laminates. Due to their technical advantages, ERS 
continue to find new applications. Epoxy resin monomers are polymer precursor units which are 
reacted with hardeners to give the polymeric material. The most commonly used epoxy resin 
monomers are diglycidyl ethers based on bisphenol A (DGEBA) (also known as BADGE) and 
bisphenol F (DGEBF or BFDGE) (Figure 1). Alternatives to DGEBA and DGEBF are receiving 
commercial interest, as epoxy resins with a variety of properties are desired. ERS are often 
modified by the addition of reactive diluents, which are used mainly to reduce the viscosity and 
improve polymerization. Phenylglycidyl ether (PGE, Figure 1) is an example of a commonly 
used reactive diluent. 
The main concerns with use of ERS at present are their environmental impact, their cytotoxicity 
and their ability to cause contact allergy. Epoxy resin monomers are among the most common 
causative agents of occupational contact dermatitis.2 Skin sensitization is known to be 
particularly common amongst construction workers and is caused by ERS present in cement and 
other building materials,3, 4 but is also frequent in newer settings such as the production of wind 
turbine rotor blades5 and epoxy pipe relining.6 Epoxy resin monomers are also implicated in non-
occupational contact allergy.7, 8 DGEBA is included in the European baseline series for diagnosis 
of contact allergy.9 ERS components other than the resin monomers have also been shown to be 
potent sensitizers.10 Allergic contact dermatitis from various epoxy resin system components6, 11-
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18 including DGEBA and DGEBF5, 19 has been reported. The skin sensitization potential has been 
investigated experimentally in vivo in mice and guinea pigs for DGEBA,20, 21 DGEBF,21, 22 
PGE23, 24 and others.25 DGEBA, DGEBF and PGE are strong sensitizers in both species 
according to regulatory classifications.26  
A number of ERS components have been demonstrated to be cytotoxic. PGE and resorcinol 
diglycidyl ether are classified by IARC as possibly carcinogenic to humans (class 2B).27 PGE is 
known to bind to and damage DNA in vitro.28 DNA damage, with sufficient dose and length of 
exposure, will trigger apoptosis and cytotoxicity.29 The genotoxicity of epoxides including PGE 
is known30 and PGE was suggested to be a direct-acting mutagen as long ago as 1979.31 A 
previous study of a series of six epoxides noted that diepoxide functionality and aromaticity 
increased the induction of apoptosis and cytotoxicity.29 It has been shown that DGEBA alkylates 
the isolated nucleophiles 4-(p-nitrobenzyl)-pyridine and deoxyguanosine.32 DGEBF is cytotoxic 
in the hepatoma cell line HepG233 and in intestinal Caco-2 cells.34 DGEBA was shown to be an 
antagonist of the nuclear transcription factor peroxisome proliferator-activated receptor-gamma 
(PPARγ) in 3T3-L1 and 3T3-F442A preadipocytes.35 PPARγ inhibitors cause apoptosis and cell 
cycle arrest in colorectal carcinoma cells.36 In contrast, DGEBA acted as a PPARγ agonist in an 
ECV403 cell line.37 Further research demonstrated that DGEBA can also induce apoptosis 
independently of PPARγ in both caspase-dependent and independent manners.38, 39 
In this work we sought to investigate which structural features of DGEBF are important for its 
skin sensitizing potency. The in vivo murine local lymph node assay (LLNA)40 and the in vitro 
KeratinoSens™ assay41 were used to determine the sensitizing effects of the compounds. We 
also assessed the in vitro cytotoxicity of DGEBF analogues in the KeratinoSens™ cell line. The 
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chemical reactivity was investigated using a model peptide and a model amino acid to estimate 
the possibility of binding to reactive residues in skin proteins. 
Experimental Procedures 
Caution: This study involves skin sensitizing compounds which must be handled with care. 
 
Instrumentation and Mode of Analysis. 1H and 13C NMR spectroscopy was performed on a 
Jeol Eclipse 400 spectrometer at 400 and 100 MHz, respectively, using CDCl3 solutions (residual 
CHCl3 δ 7.26 and CHCl3 δ 77.0 as internal standards). Electron-ionization mass spectral analysis 
(70 eV) was performed on a Hewlett-Packard 5973 mass spectrometer connected to a gas 
chromatograph (Hewlett-Packard 6890). The GC was equipped with a cool on-column capillary 
inlet and an HP-5MSi fused silica capillary column (30 m × 0.25 mm, 0.25 µm, Agilent 
Technologies, Palo Alto, CA). Helium was used as carrier gas, and the flow rate was 1.2 
mL/min. The temperature program started at 70 °C for 1 min, increased by 10 °C/min, and ended 
at 270 °C for 5 min. For mass spectral analysis, the mass spectrometer was used in the scan 
mode detecting ions with m/z values ranging from 50 to 1500. 
 
High performance liquid chromatography/mass spectrometry (LC/MS) analyses were performed 
using electrospray ionization (EIS) on a Hewlett-Packard 1100 HPLC/MS. The system included 
a vacuum degasser, a binary pump, an autoinjector, a column thermostat, a diode array detector, 
and a single quadrupole mass spectrometer. The HPLC was equipped with a HyPURITY C18 
column (150 × 3 mm i. d., particle size 3 µm, Thermo Hypersil-Keystone, Thermo Electron 
Corp., Bellafonte, PA). The mobile phase consisted of 0.005% pentafluoropropanoic acid, 0.1% 
acetic acid, and 5% acetonitrile in water (solvent A) and 0.005% pentafluoropropanoic acid, 
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0.1% acetic acid, and 50% water in acetonitrile (solvent B). A linear gradient from 0% to 100% 
B in 20 min, followed by 10 min of isocratic elution was used. The flow rate was 0.40 mL/min 
and the column temperature was set to 40 °C. The electrospray interface was used with the 
following spray chamber settings: nebulizer pressure, 40 psig; capillary voltage, 3500 V; drying 
gas temperature, 350 °C; and drying gas flow rate, 10 L/min. Fragmentor voltage was set to 120 
V. The mass spectrometer was used in scan mode detecting molecular ions with m/z values 
ranging from 50 to 2000. 
 
DGEBA, DGEBF, PGE and 3 (Figure 1) were purchased from Sigma-Aldrich; DGEBF was 
obtained as a mixture of three isomers. Resorcinol diglycidyl ether (3) was 91% pure when 
purchased and was further purified by column chromatography (hexane: ethyl acetate 7:3) prior 
to evaluation. Acetone was purchased from Merck (Darmstadt, Germany) and olive oil from 
Apoteket AB (Goteborg, Sweden). The peptide AcPHCKRM was purchased from Peptide 2.0 
Inc. (Chantilly, USA). Unless otherwise indicated, reagents were obtained from commercial 
suppliers and used without further purification. TLC was performed using silica gel coated 
aluminium plates. The purity of both synthesized and purchased test compounds was >98% 




2-((4-(4-(2-Methoxyethoxy)benzyl)phenoxy)methyl)oxirane (1) (Scheme 1A). 
4-(2-Methoxyethoxy)benzoic acid (7): A solution of KOH (9.40 g, 166 mmol) in anhydrous 
ethanol (85 mL) was added to a solution of 4-hydroxybenzoic acid (10.0 g, 72.4 mmol) in 
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anhydrous ethanol (115 mL) under nitrogen atmosphere. The white suspension was stirred with 
dropwise addition of 2-bromo-1-methoxyethane (8.84 mL, 13.0 g, 94.1 mmol). The reaction 
mixture was refluxed for 24 h under nitrogen atmosphere. A solution of KOH (8.25 g, 63.5 
mmol) in anhydrous ethanol (75 mL) was added and the reaction mixture was refluxed for a 
further 2 h. After evaporation of the solvent, the residue was dissolved in water (500 mL) and 
acidified to pH=1 with diluted HCl (1 N). The precipitate was isolated by filtration, dried and 
purified by recrystallization in ethanol, to give 7 (12.14 g, 86%) as white crystals. 1H NMR δ 
3.46 (3H, s), 3.78 (2H, t, J=9.26 Hz), 4.19 (2H, t, J=9.52 Hz), 6.97 (2H, d, J=8.79 Hz) 8.05 (2H, 
d, J=8.79 Hz). 13C NMR δ 59.3, 67.4, 70.7, 114.3, 121.8, 132.3, 163.2, 171.3. ESI-MS (70 eV), 
m/z (%) 196 (66) (M+), 179 (2), 164 (1), 151 (6), 138 (13), 121 (33), 105 (6), 93 (5), 76 (6), 59 
(100). 
 
N-Methoxy-4-(2-methoxyethoxy)-N-methylbenzamide (8): N-Methylmorpholine (2.8 mL, 
2.49 g, 25.4 mmol) was added dropwise to a solution of 7 (4.64 g, 23.7 mmol) in freshly distilled 
THF (35 mL) under nitrogen atmosphere. Isopropyl chloroformate (27.8 mL, 26 mmol) was 
added dropwise at -20 ºC and the reaction mixture was stirred for 30 min at -20 ºC. Freshly 
distilled triethylamine (5.2 mL, 37.3 mmol) was added to a suspension of N,O-
dimethylhydroxylamine hydrochloride (3.63 g, 37.6 mmol), in anhydrous DMF (20 mL). The 
suspension was added to the reaction mixture at 0 ºC. After 3.5 hours at 0 ºC, the reaction 
mixture was quenched with water (300 mL). The aqueous phase was extracted with ethyl acetate 
(3 × 100 mL). The combined organic layers were washed with HCl (1 N) (125 mL), saturated 
aqueous NaHCO3 (125 mL) and brine (125 mL) and were dried over anhydrous Na2SO4, filtered 
and concentrated in vacuo. The yellow oil was purified by column chromatography (CH3OH: 
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CH2Cl2, 0.5: 99.5) (Rf = 0.32), to give 8 (3.22 g, 57%) as a colorless oil. 
1H NMR δ 3.35 (3H, s), 
3.46 (3H, s), 3.55 (3H, s), 3.74-3.80 (2H, m), 4.13-4.18 (2H, m), 6.93 (2H, d, J=8.79 Hz), 7.71 
(2H, d, J=8.79 Hz). 13C NMR δ 33.9, 59.2, 60.8, 67.3, 70.8, 113.8, 126.2, 130.5, 160.7, 169.3. 
ESI-MS (70 eV), m/z (%) 239 (2) (M+), 209 (1), 179 (100), 135 (4), 121 (82), 104 (7), 93 (9), 76 
(6), 59 (20). 
 
(4-tert-Butyldimethylsilyloxyphenyl)(4-(2-methoxyethoxy)phenyl)methanone (9): A solution 
of (4-bromophenoxy)-tert-butyldimethylsilane (97%) (5.02 mL, 5.92 g, 20 mmol) in freshly 
distilled THF (20.0 mL) under nitrogen atmosphere was stirred for 5 min and then cooled to -78 
°C. After stirring for a further 10 min, N-butyllithium (2.5 M in hexanes) (8.4 mL, 22 mmol, 2 
equiv) was added dropwise to the solution. The temperature was kept at -78 °C for 20 min, and 
then kept at -40 °C for 40 min. A solution of 8 (2.39 g, 10 mmol) in freshly distilled THF (15 
mL) was added dropwise to the in situ generated aryllithium under nitrogen atmosphere at -78 
°C. The temperature was kept at -78 °C for 1 h, then kept at -30 °C for 40 min and then kept at 
room temperature for 1.5 h. Aqueous HCl (1 N) (13 mL) was added and after 30 min, the 
biphasic mixture was partitioned between chloroform (30 mL) and water (50 mL). The organic 
phase was washed with saturated, aqueous NaHCO3 (3 × 100 mL). The combined organic layers 
were dried with anhydrous Na2SO4 and concentrated in vacuo. The yellow oil was purified by 
column chromatography (hexane: ethyl acetate, 5:1) (Rf = 0.22), to give 9 (3.66 g, 95%) as a 
colorless oil. 1H NMR δ 0.25 (6H, s), 1.00 (9H, s), 3.47 (3H, s), 3.77-3.81 (2H, m), 4.18-4.22 
(2H, m), 6.89 (2H, d, J=8.79 Hz), 6.98 (2H, d, J=8.79 Hz), 7.72 (2H, d, J=8.79 Hz), 7.78 (2H, d, 
J=8.79 Hz). 13C NMR δ -4.4, 18.2, 25.6, 59.3, 67.4, 70.8, 114.0, 119.6, 130.9, 131.3, 132.1, 
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132.2, 159.5, 162.0, 194.6. ESI-MS (70 eV), m/z (%) 386 (100) (M+), 329 (99), 270 (21), 209 
(91), 179 (68), 121 (69). 
 
1-tert-Butyldimethylsilyloxy-4-(4-(2-methoxyethoxy)benzyl)benzene (10): Solid zinc iodide 
(3.89 g, 12.2 mmol) and sodium cyanoborohydride (3.82 g, 60.9 mmol) were added to a solution 
of 9 (3.14 g, 8.12 mmol) in 1,2-dichloroethane (40 mL) at room temperature. After 20 h, the 
reaction mixture was filtered through Celite and the Celite was washed with CH2Cl2 The filtrate 
was concentrated in vacuo, to give 10 (3.01 g, 98%) as a colorless oil. 1H NMR δ 0.17 (6H, s), 
0.97 (9H, s), 3.45 (3H, s), 3.72-3.77 (2H, m), 3.85 (2H, s), 4.08-4.12 (2H, m), 6.74 (2H, d, 
J=8.42 Hz), 6.85 (2H, d, J=8.42 Hz), 7.00 (2H, d, J=8.42 Hz), 7.07 (2H, d, J=8.42 Hz). 13C NMR 
δ -4.5, 18.2, 25.7, 40.2, 59.2, 67.2, 71.0, 114.5, 119.9, 129.6, 129.7, 133.9, 134.2, 153.8, 157.0. 
ESI-MS (70 eV), m/z (%) 372 (87) (M+), 316 (19), 287 (6), 256 (13), 195 (100), 165 (18), 150 
(8), 133 (29), 107 (19), 89 (25), 73 (6), 59 (14). 
 
4-(4-(2-Methoxyethoxy)benzyl)phenol (11): A solution of tetra-n-butylammonium fluoride in 
THF (1 M) (8.5 mL, 8.5 mmol) was added to a solution of 10 (3.0 g, 8.08 mmol) in freshly 
distilled THF (33 mL) under nitrogen atmosphere. After 3 h at room temperature, the reaction 
mixture was diluted with ethyl acetate (75 mL) and washed with a saturated solution of NH4Cl 
(140 mL). The aqueous layer was extracted with ethyl acetate (3 × 75 mL). The combined 
organic layers were washed with water (2 × 175 mL), brine (175 mL), dried over anhydrous 
Na2SO4 and concentrated in vacuo. The white crystals were purified by column chromatography 
(CH3OH: toluene, 6:94) (Rf = 0.55), to give 11 (1.87 g, 90%) as white crystals. 
1H NMR δ 3.45 
(3H, s), 3.75 (2H, t, J=9.52 Hz), 3.84 (2H, s), 4.10 (2H, t, J=9.52 Hz), 6.74 (2H, d, J=8.06 Hz), 
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6.84 (2H, d, J=8.42 Hz), 7.02 (2H, d, J=8.42 Hz), 7.06 (2H, d, J=8.42 Hz). 13C NMR δ 40.1, 
59.2, 67.2, 71.1, 114.6, 115.2, 129.7, 129.9, 133.7, 133.9, 153.8, 157.0. ESI-MS (70 eV), m/z (%) 
258 (100) (M+), 199 (40), 183 (16), 165 (9), 152 (11), 107 (51), 94 (6), 77 (6), 59 (47). 
 
2-((4-(4-(2-Methoxyethoxy)benzyl)phenoxy)methyl)oxirane (1): Epichlorohydrin (1.14 mL, 
14.4 mmol) was added dropwise to a reaction mixture of 11 (0.92 g, 3.74 mmol) and Cs2CO3 
(2.34 g, 7.12 mmol) in freshly distilled acetonitrile (60 mL). The reaction mixture was refluxed 
for 3 h under nitrogen atmosphere. Water (100 mL) and ethyl acetate (50 mL) were added at 
room temperature and the separated water phase was extracted with ethyl acetate (3 × 60 mL). 
The combined organic layers were washed with brine (200 mL), water (200 mL) and brine (200 
mL), dried over anhydrous Na2SO4 and concentrated in vacuo. The mixture was purified by 
column chromatography (CH3OH: CH2Cl2, 1:99) (Rf = 0.47) to give 1 (0.91 g, 78%) as white 
crystals. 1H NMR δ 2.4 (1H, dd, J=4.76, 2.56 Hz), 2.89 (1H, t, J=8.79 Hz), 3.31-3.37 (1H, m), 
3.44 (3H, s), 3.71-3.76 (2H, m), 3.86 (2H, s), 3.90-3.97 (1H, m), 4.06-4.12 (3H, m), 4.15-4.21 
(1H, m), 6.81-6.88 (4H, m), 7.04-7.11 (4H, m). 13C NMR δ 40.1, 44.7, 50.1, 59.2, 67.2, 68.8, 
71.0, 114.6, 129.7, 129.8, 133.8, 134.3, 156.8, 157.1. LC/MS (API-ES, 120 V) m/z (%): 337.1 
[M+Na] (40), 332.1 [M+H2O] (100), 315.1 [M+H] (3), 165.1 (58), 163.1 (51.5), 107.1 (9), 59.1 
(8.3). 
 
Bis(4-(2-methoxyethoxy)phenyl)methane (2) (Scheme 1B). A solution of potassium hydroxide 
(0.74 g, 13.2 mmol) in anhydrous ethanol (ca 10 mL) was added to a solution of 4,4'-
methylenediphenol (1.10 g, 5.5 mmol) in anhydrous ethanol. 2-Bromo-1-methoxyethane (1.34 
mL, 14.3 mmol) was added and the reaction was refluxed for 4 h. The solvent was evaporated 
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and the residue was diluted with ethyl acetate (70 mL) and washed successively with HCl (1 M, 
50 mL), NaOH (2 M, 50 mL) and water (50 mL), and then dried over Na2SO4. The solvent was 
evaporated in vacuo. The product was purified by column chromatography (CH3OH: CH2Cl2, 
0:100, then 0.25:99.75 then 0.5:99.5) to give pure 2 (0.50 g, 29%). 1H NMR δ 3.43 (6H, s), 3.71-
3.74 (4H, m), 3.85 (2H, s), 4.07-4.09 (4H, m), 6.83 (4H, d, J=6.6 Hz), 7.96 (4H, d, J=8.8 Hz). 
13C NMR δ 40.2, 59.3, 67.3, 71.2, 114.6, 123.8, 134.0, 157.2. ESI-MS (70 eV) m/z (%) 316 (100) 
(M+), 257 (18), 207 (34), 199 (19), 107 (19), 59 (66). 
 
(2-Methoxyethoxy)benzene (4) (Scheme 1C). A solution of KOH (12 mmol) in dry ethanol (5 
mL) was added to phenol (0.49 g, 5.3 mmol) in dry ethanol (5 mL). 2-Bromo-1-methoxyethane 
(0.65 mL, 6.9 mmol) was added and the reaction was refluxed for 4 h. The solvent was 
evaporated and the residue was dissolved in ethyl acetate (70 mL). The organic layer was washed 
successively with HCl (1M, 50 mL), NaOH (2 M, 50 mL) and water (50 mL) and was dried over 
Na2SO4. The solvent was evaporated in vacuo. The product was purified by column 
chromatography (hexane: ethyl acetate 9:1) to yield 4 (0.22 g, 27%). 1H NMR δ 3.45 (3H, s), 
3.73 - 3.76 (2H, m), 4.11-4.13 (2H, m), 6.93-6.95 (3H, m), 7.26-7.30 (2H, m). 13C NMR δ 59.3, 
67.2, 71.1, 114.7, 120.9, 129.5, 158.8. ESI-MS (70eV) m/z (%) 152 (61) (M+), 107 (11), 94 (55), 
77 (51), 65 (17), 59 (100), 51 (17). 
 
1,5-Bis(2,3-epoxypropoxy)pentane (5) (Scheme 2). 
1,5-Bis(allyloxy)pentane (12): Sodium hydride (0.62 g, 26 mmol, 5.2 equiv) was washed with 
hexane (20 mL × 2), suspended in anhydrous THF (40 mL) and cooled to 0 ⁰C. Pentane-1,5-diol 
(0.52 g, 5.0 mmol) was dissolved in anhydrous THF (20 mL) and added to the suspension. The 
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mixture was stirred at 0 ⁰C for 10 min. Allyl bromide (1.12 mL, 13 mmol, 2.6 equiv) was added 
and the mixture was stirred at room temperature for 90 min before refluxing overnight. The 
reaction was continued until TLC indicated disappearance of the starting material. The mixture 
was cooled to 0 ⁰C and saturated aqueous NH4Cl (70 mL) was added slowly to quench the 
reaction. The aqueous layer was extracted with ethyl acetate (70 mL × 3). The combined organic 
fractions were washed with brine (150 mL), dried over anhydrous Na2SO4 and reduced in vacuo. 
Compound 12 was obtained as a colorless oil (0.70 g, 76%). 1H NMR δ 1.35-1.41 (m, 2H), 1.53-
1.59 (m, 4H), 3.36 (t, 4H, J=6.6 Hz), 3.90-3.91 (m, 4H), 5.09-5.12 (m, 2H), 5.18-5.25 (m, 2H), 
5.81-5.90 (m, 2H). 13C NMR δ 22.9 (CH2), 29.6 (CH2), 70.3 (CH2), 71.8 (CH2), 116.7 (CH2), 
135.1 (CH). EI-MS (70 eV), m/z (%) 143 (12), 127 (13), 97 (7), 85 (100), 69 (47), 57 (26). 
 
1,5-Bis(2,3-epoxypropoxy)pentane (5): A solution of 12 (0.7 g, 3.8 mmol) in chloroform (20 
mL) was cooled to 0 ⁰C. 3-Chloroperbenzoic acid (≤77%, 1.96 g, 11.4 mmol) was added and the 
mixture was stirred at 0 ⁰C for 2 h. The mixture was then stirred at room temperature with 
further additions of 3-chloroperbenzoic acid until the reaction was complete according to TLC. 
Aqueous NaOH (40 mL) (10% w/v) was added and the aqueous phase was extracted with 
CH2Cl2 (40 mL). The organic phase was washed with brine (40 mL), dried over anhydrous 
Na2SO4 and reduced in vacuo. Compound 5 was isolated as a colorless oil (0.50 g, 61%) after 
column chromatography (hexane: ethyl acetate, 8:2). 1H NMR δ 1.35-1.39 (m, 2H), 1.52-1.60 
(m, 4H), 2.54-2.56 (m, 2H), 2.73-2.75 (m, 2H), 3.07-3.11 (m, 2H), 3.29-3.33 (m, 2H), 3.39-3.49 
(m, 4H), 3.67 (dd, 2H, J=2.96, 11.72 Hz). 13C NMR δ 22.7, 29.5, 44.3, 50.9, 71.5. EI-MS (70 




1,7-Bis(2,3-Epoxypropoxy)heptane (6) (Scheme 2).  
1,7-Bis(allyloxy)heptane (13): Sodium hydride (0.62 g, 26 mmol, 5.2 equiv) was washed with 
hexane (2 × 20 mL), suspended in anhydrous THF (40 mL) and cooled to 0 ⁰C. Heptane-1,7-diol 
(0.66 g, 5.0 mmol) was dissolved in anhydrous THF (20 mL) and added to the suspension. The 
mixture was stirred at 0 ⁰C for 10 min. Allyl bromide (1.56 g, 13 mmol, 2.6 equiv) was added 
and the mixture was stirred at room temperature for 90 min before refluxing overnight. The 
reaction was continued until TLC indicated disappearance of the starting material. The mixture 
was cooled to 0 ⁰C and saturated aqueous NH4Cl (70 mL) was added slowly to quench the 
reaction. The aqueous layer was extracted with ethyl acetate (3 × 70 mL). The combined organic 
fractions were washed with brine (150 mL), dried over anhydrous Na2SO4 and reduced in vacuo. 
Compound 13 was obtained as a colorless oil (0.81 g, 76%). 1H NMR δ 1.24-1.36 (m, 6H), 1.51-
1.57 (m, 4H), 3.38 (t, 4H, J=6.6 Hz), 3.91-3.93 (m, 4H), 5.11-5.14 (m, 2H), 5.21-5.26 (m, 2H), 
5.83-5.92 (m, 2H). 13C NMR δ 26.2, 29.4, 29.8, 70.5, 71.9, 116.8, 135.1. EI-MS (70 eV), m/z 
(%) 171 (19), 125 (5), 113 (21), 97 (65), 81 (17), 71 (42), 55 (100). 
 
1,7-Bis(2,3-epoxypropoxy)heptane (6): A solution of 13 (0.8 g, 3.8 mmol) in chloroform (20 
mL) was cooled to 0 ⁰C. 3-Chloroperbenzoic acid (≤77%, 1.96 g, 11.4 mmol) was added and the 
mixture was stirred at 0 ⁰C for 2 h. The mixture was then stirred at room temperature with 
further additions of 3-chloroperbenzoic acid until the reaction was complete according to TLC. 
Aqueous NaOH (40 mL) (10% w/v) was added and the aqueous phase was extracted with 
CH2Cl2 (40 mL). The organic phase was washed with brine (40 mL), dried over anhydrous 
Na2SO4 and reduced in vacuo. Purification by column chromatography (hexane: ethyl acetate, 
8:2) gave 6 as a colorless oil (0.54 g, 58%). 1H NMR δ 1.29-1.32 (m, 6H), 1.51-1.55 (m, 4H), 
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2.55-2.57 (m, 2H), 2.74-2.76 (m, 2H), 3.07-3.11 (m, 2H), 3.30-3.35 (m, 2H), 3.38-3.48 (m, 4H), 
3.64-3.68 (m, 2H). 13C NMR δ 26.1, 29.3, 29.7, 44.4, 50.9, 71.5, 71.7. EI-MS (70 eV), m/z (%) 
141 (1), 127 (3), 113 (12), 95 (74), 87 (10), 81 (16), 75 (12), 69 (48), 55 (100). 
 
Experimental Animals. Female CBA/Ca mice, 8 or 9 weeks of age, were purchased from 
NOVA SCB Charles River, Germany. The mice were housed in “hepa” filtered air flow cages 
and kept on standard laboratory diet and water ad lib. The local ethics committee in Gothenburg 
approved the study.  
 
Skin Sensitization Potency of Epoxy Resins in Mice. The local lymph node assay (LLNA)40 
was used to assess the sensitization potency. Mice in six groups of three animals in each were 
treated by topical application on the dorsum of both ears with the test compound (25 µL) 
dissolved in acetone:olive oil (AOO) (4:1 v/v) or with the vehicle control. All solutions were 
freshly prepared for each application. Each compound was tested at five different concentrations. 
The test concentrations used were as follows: 1 and 2: 1, 5, 10, 20 and 30% (w/v); Treatments 
were performed daily for three consecutive days (days 0, 1, and 2). Sham treated control animals 
received vehicle alone. On day 5, all mice were injected intravenously via the tail vein with 
[methyl-3H]thymidine (2.0 Ci/mmol, Amersham Biosciences, UK) (20 µCi) in phosphate-
buffered saline (PBS, containing 137 mM NaCl, 2.7 mM KCl and 10 mM phosphate buffer, pH 
7.4) (250 µL). After 5 h the mice were sacrificed, the draining lymph nodes were excised and 
pooled for each group, and single cell suspensions of lymph-node cells in PBS were prepared 
using cell strainers (Falcon, BD labware, 70 µm pore size). Cell suspensions were washed twice 
with PBS, precipitated with TCA (5%) and left in the refrigerator overnight. The samples were 
 15 
 
then centrifuged, resuspended in TCA (5%) (1 mL) and transferred to a scintillation cocktail (10 
mL) (EcoLume, INC Radiochemicals, USA). The [methyl-3H]thymidine incorporation into DNA 
was measured by β-scintillation counting on Beckman LS 6000TA Instruments. Results are 
expressed as mean dpm/lymph node for each experimental group and as stimulation index (SI), 
i.e., test group/control group ratio. Test materials that at one or more concentrations caused an SI 
greater than 3 were considered to be positive in the LLNA. EC3 values (the estimated 
concentration required to induce an SI of 3) were calculated by linear interpolation. The 
sensitization potency was classified to the following: ≤0.2% w/v, extreme; >0.2 to ≤2% w/v, 
strong; >2% w/v moderate.26 
KeratinoSens™ Assay for Sensitization and Cellular Viability. The KeratinoSens™ assay 
was performed as previously described in detail.41, 42 Briefly, cells were grown for 24 h in 96-
well plates. The medium was then replaced with medium containing the test chemical and a final 
level of 1% DMSO. Each compound was tested at 12 binary dilutions in the range from 0.98 to 
2000 µM. Each test plate contained seven test chemicals, six wells with the solvent control, one 
well with no cells for background value and five wells with the positive control cinnamic 
aldehyde in five different concentrations. In each repetition, three parallel replicate plates were 
run with this same set-up and a fourth parallel plate was prepared for cytotoxicity determination. 
Cells were incubated for 48 h with the test agents, after which luciferase activity and cytotoxicity 
(with the MTT assay43) were determined. This full procedure was repeated three times for each 
chemical. 
Thiol Reactivity with N-Acetyl Cysteine Methyl Ester. Compound DGEBF or 2 (1 mmol) was 
stirred with N-ACME (1 mmol) at 37 °C overnight in a 2:1 solution of DMSO: ammonium 
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acetate buffer (100 mM pH 7.4). The reaction was analyzed using LC/MS (see parameters 
above). 
Reactivity with the Model Peptide Ac-Pro-His-Cys-Lys-Arg-Met-OH (AcPHCKRM). All 
solvents were degassed with argon prior to use. The hexapeptide AcPHCKRM (Peptide 2.0) was 
>99% pure as determined by HPLC (UV220nm). Bz-His-OMe (Bachem) was used as an internal 
standard. Solutions of PGE, DGEBF or compound 1 in DMSO (40 mM, 100 µL) together with 
potassium phosphate buffer (100 mM, pH 7.4), (200 µL) were added to a vial purged with argon 
containing AcPHCKRM in DMSO (4 mM, 100 µL). Accordingly, final concentrations of 
compound and model peptide in the reaction mixture were 10 mM and 1 mM, respectively. The 
reaction mixture was kept under argon at room temperature and was monitored with 
UV210nm/ESI-MS. As the HPLC run time was 40 minutes, data was combined from two 
experiments. In the first experiment, samples were collected at t=0, 40, 80, 120 mins and in the 
second experiment at t=20, 60, 100 mins. In a modified experiment using two haptens 
simultaneously, 50 μL of both PGE and DGEBF (50 mM) were added to the solution containing 





Results and Discussion 
Chemical Synthesis 
Efficient synthetic strategies were employed to produce the biaromatic compounds 1 and 2 
illustrated in Figure 1. A six-step synthesis was used to obtain the non-symmetrical compound 1 
(Scheme 1, A). 2-Bromoethyl methyl ether and 4-hydroxybenzoic acid were reacted (step i) and 
the isolated product 7 was subsequently reacted with N,O-dimethylhydroxylamine hydrochloride 
to produce the Weinreb amide 8 (step ii). The amide 8 was then coupled to 1-bromo-4-tert-
butyldimethylsilyloxybenzene to yield the biaromatic product 9 (step iii). After reduction (step 
iv) and deprotection (step v), the final product 1 was obtained by alkylation of the free phenolic 
group with epichlorohydrin in 32% overall yield (step vi).  
Synthesis of 2 was achieved in a one-step reaction in a moderate yield of 29% (Scheme 1, B). 
The monoalkylated compound was isolated as a by-product. Synthesis of 4 was achieved from 
phenol in 27% yield (Scheme 1, C). Both 1 and 2 were synthesized as tools to investigate the 
effects of the epoxide functionalities of DGEBF and cannot be used as epoxy resin monomer 
replacements for polymer synthesis. Compound 1, with one terminal epoxide group and one 
terminal methoxy group, can only form dimers and compound 2, with two terminal methoxy 
groups, cannot react with itself or other epoxide-containing polymeric precursors.  
Linear compounds 5 and 6 were synthesized to investigate the influence of sterical shape on the 
cytotoxicity of 2. A 5-carbon chain was chosen as it most closely imitates the inter-atomic 
distance between the two epoxide groups of DGEBF (14.47 Å for 5 compared to 14.75 Å for 
DGEBF) (Table S1, Supporting Information). The compound with a 7-carbon chain, 6, was also 
synthesized to obtain supplemental information. These linear epoxides have greater flexibility 
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than DGEBF and hence there are a large number of conformations possible. Compounds 5 and 6 
were obtained in two steps from 1,5-pentanediol and 1,7-heptanediol, respectively (Scheme 2). 
The diallylic intermediates 12 and 13 were each obtained in 76% yield by refluxing the starting 
material with allyl bromide and sodium hydride in an inert atmosphere (step i). The final 
compounds are formed by epoxidation using meta-chloroperbenzoic acid (mCPBA) (step ii). The 
corresponding monoepoxides were observed as by-products.  
Skin Sensitization Potency Studies: LLNA and KeratinoSens™ 
Biaromatic compounds 1 and 2 were assessed in vivo for skin sensitization potency using the 
murine local lymph node assay (LLNA).44 LLNA results are expressed as EC3 values, which is 
the estimated concentration of a substance required to induce a 3-fold increase in sensitization 
compared to a control.  
The EC3 value obtained for compound 1 was 74 mM (2.3% w/v) (Figure 2 and Table S2, 
Supporting Information). The stimulation index decreases for the 20% and 30% concentrations 
compared to that of 10%. This effect was seen in repeated LLNA experiments with 1. Previously 
reported LLNA EC3 values for DGEBA, DGEBF and PGE indicate that they are equipotent at 
36 mM, 36 mM and 31 mM (1.2, 1.1 and 0.46% w/v), respectively.21, 23 According to suggested 
regulatory classifications, all three are sensitizers of strong potency.26 The monoepoxide 1 has 
reduced sensitization potency in the LLNA compared to DGEBF and is classified as a moderate 
sensitizer according to its EC3 value of 2.3% w/v. Compound 2 does not contain any reactive 
epoxide groups and was non-sensitizing in concentrations up to 30% w/v (950 mM) (Figure 2). 
This compound did not show any dose-response relationship at the concentrations tested. The 
only structural difference between compound 2 and DGEBF is lack of epoxide groups in 
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compound 2 (Figure 1). Thus, our results show that epoxide groups are directly responsible for 
the skin sensitization effects of DGEBF in the LLNA. 
To obtain further information, all compounds were evaluated in the in vitro KeratinoSens™ 
assay.42 In this assay, compounds are rated as skin sensitizers if they induce the luciferase gene 
by greater than 1.5-fold at non-cytotoxic concentrations. Previously published values predict 
DGEBA, DGEBF and PGE to be sensitizers, giving a 1.5-fold induction at low micromolar 
concentrations.21 The KeratinoSens™ assay predicts 1 as a sensitizer (Table 1). Partial 
cytotoxicity of a chemical may lead to a luciferase induction in dying cells and therefore 
chemicals are rated as sensitizers only when luciferase induction starts at non-cytotoxic 
concentrations.42 For compound 2, >1.5-fold induction can only be noted at cytotoxic 
concentrations, and thus 2 is classified as a non-sensitizer by this method. The KeratinoSens™ 
results for both biaromatic compounds are in agreement with the LLNA data. 
Linear diepoxides 5 and 6 were predicted to be sensitizers by the KeratinoSens™, with 
maximum induction values (Imax) of 209 and 43, respectively. These compounds were not 
evaluated in the LLNA due to ethical considerations, but it is not surprising that they are 
predicted to be sensitizers as both contain two terminal, reactive epoxide groups. A structurally 
related compound, 1,6-hexanediol diglycidyl ether, has a reported EC3 value of 1.9% w/v, 
classifying it as a strong sensitizer.25 
Two monoaromatic compounds were also assessed in the KeratinoSensTM. Of these, epoxide 
containing compound 3 was predicted to be a skin sensitizer (Imax = 120), while non-epoxide 4 
was predicted as a non-sensitizer (Imax = 1.2). Neither 3 nor 4 were assessed in the LLNA, again 
due to ethical considerations. On the basis of the results above, 3 would be expected to be a 
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strong sensitizer in the LLNA due to the presence of the epoxide groups, analogous to PGE.21 
Conversely, 4 is structurally related to 2 and would not be expected to act as a sensitizer due to 
the lack of epoxide groups.  
Reactivity Towards the Thiol Residue in Cysteine and in a Model Peptide 
Small molecules react with reactive amino acid residues of proteins in the skin to form 
immunogenic complexes, which are then recognized by the immune systems as ‘non-self’ and 
provoke an immune response. Reactive amino acid residues that play a role in skin sensitization 
include cysteines (thiol), lysines (amino) and to a lesser extent arginines, histidines, methionines 
and tyrosines.45 It has been previously demonstrated that the epoxy reactive diluent PGE reacts 
selectively with the thiol residue of a model peptide.23 We firstly investigated the reactivity of 
DGEBF and compound 2 with a cysteine derivative (N-acetyl-L-cysteine methyl ester, N-
ACME). LC/MS analysis of the DGEBF/N-ACME reaction after 24 hours showed the formation 
of both monoadducts and diadducts, indicating that DGEBF is thiol-reactive. There was no 
reaction between 2 and N-ACME, indicating that 2 is non-reactive towards free thiols. Further 
reactions of compound 2 were not investigated, but we would predict that the methoxy group is 
also unreactive towards other amino acids implicated in skin sensitization. The results of the 
reactivity experiment with N-ACME indicate that the epoxide groups of DGEBF are necessary 
for thiol binding. 
Having confirmed that the epoxide group was required to react with cysteine, the reactivities of 
DGEBF, compound 1 and PGE towards a model peptide were investigated. The three 
compounds were chosen to investigate the relative reactivity of a biaromatic diepoxide, a 
biaromatic monoepoxide and a monoaromatic monoepoxide. The hexapeptide chosen, 
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AcPHCKRM, contains both cysteine and lysine amino acid residues. All compounds were stable 
in the conditions of the assay.  
The percentage peptide depletion was calculated for the three compounds (Figure 3 and Table 
S3, Supporting Information). DGEBF and compound 1 are structurally similar with the only 
difference being one terminal epoxide group in compound 1 compared to two in DGEBF. The 
depletion is slightly faster for DGEBF compared to compound 1. The reactivity of DGEBF is 
similar to that of PGE at 120 min (7.1% of free peptide remaining). To confirm the latter result, a 
second experiment was performed in which both DGEBF and PGE were allowed to react 
simultaneously with the peptide. 51.5% of DGEBF-peptide adduct was formed compared to 
48.5% of PGE-peptide adduct, confirming that DGEBF and PGE react with this peptide in 
essentially equimolar amounts.  
Interestingly, the diepoxide DGEBF was observed to only form mono-adducts and did not cross-
link peptides. This result is unexpected, as the ability to cross-link proteins could be a potential 
reason for the enhanced response of DGEBF in the LLNA over compound 1. A potential reason 
for the lack of cross-linking observed is that an excess of DGEBF compared to peptide is used in 
this assay (10:1 ratio). 
A cysteine adduct was observed for all three compounds, indicated by haptenated y5 and y4 
fragments in the MS, but non-haptenated y3 and y2 fragments (Table 2 and Figure S1, 
Supporting Information). No adducts with lysine or other residues were observed. This is in 
agreement with previous results showing that the epoxides bind to cysteine residues in 
peptides.23, 46  
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In summary, the reactivity experiments indicate that both the biaromatic and monoaromatic 
epoxide-containing compounds DGEBF, compound 1 and PGE can bind to thiol residues, while 
compound 2 cannot. This explains the lack of sensitizing effects shown by 2 in the LLNA and 
KeratinoSens™. 
Cytotoxicity 
All compounds were screened for in vitro cytotoxicity in the KeratinoSens™ cell line using the 
MTT assay (Table 1).43 The IC50 values for the four biaromatic compounds DGEBA, DGEBF, 1 
and 2 fall in the low micromolar range between 22 and 69 μM. Linear diepoxide 6 (IC50=169 
μM) was over 7-fold less cytotoxic compared to both DGEBA and DGEBF. Compound 5 was 
the least cytotoxic of the epoxide-containing compounds (IC50=284 μM). Cytotoxicity of 
monoaromatic diepoxide 3 (IC50=38 μM) was in the same range as that of DGEBF, 1 and 2. The 
monoepoxide PGE has an IC50 value of 182 μM while compound 4 did not reduce viability by 
50% or more at concentrations up to 2,000 μM. 
DGEBA is known both as an alkylating agent and as a PPARγ antagonist.32, 35 It is unknown at 
present if DGEBA covalently modifies the PPARγ receptor.47 It is anticipated that DGEBF 
causes cell death by similar mechanisms to DGEBA due to their structural similarity. The 
relative loss in cytotoxic potency of the two linear epoxides 5 and 6 compared to DGEBF may 
indicate that terminal epoxides are not the only structural feature required for potent cytotoxicity 
in this cell line. DGEBF and compound 2 have equipotent cytotoxicity indicating that a 
structurally similar compound without reactive epoxides may have a similar cytotoxicity in 
monolayer cell culture. This is in contrast to the results observed for skin sensitization, where the 
presence of epoxide groups was essential for sensitizing effects. 
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The nature of the alkyl chain has a large impact on in vitro cytotoxicity when comparing 
monoaromatic compounds PGE and 4. PGE is known to cause cell death via reactive 
mechanisms, including DNA-damage,48 activation of heat shock response and antioxidant 
response.49 PGE forms DNA-adducts via its epoxide group, causing cytotoxicity and apoptosis. 
Compound 4 lacks the epoxide group, and therefore cannot bind to cellular thiols or cause cell 
death by reactive mechanisms. Our results indicate that a reactive group is necessary for the 
cytotoxic effect of the monoaromatic epoxides PGE and 3 in the cell line used in our study.  
Conclusion 
The aim of our work was to investigate the skin sensitizing potency and in vitro cytotoxicity of 
analogues of the epoxy resin monomer DGEBF. These results have implications for the 
development of new ERS components. We have shown that the skin sensitization potency of the 
epoxy resin monomer DGEBF is due to its terminal epoxide groups. Based on our findings, 
newly reported epoxy resin monomers50, 51 would be expected to cause skin sensitization and 
allergic contact dermatitis as they contain terminal epoxide groups. Our results also imply that 
there is a need for further research to try to decrease the reactivity of the epoxide groups to a 
level where the contact sensitization is reduced but the polymerization capacity is still intact. We 
have shown that the cytotoxicity of DGEBF in monolayer cell culture may not only be dependent 
on the epoxide groups. Depending on the structure of alternative epoxy resins,50-52 reduced 
cytotoxicity might be obtained. It is important to keep the potential adverse health effects of 
epoxy resins in mind when developing a new system and to assess these effects at an early stage 
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Table 1. Results from the KeratinoSens™ assaya 
Compound 







DGEBA21 13 Sensitizer 5.2 10 22 
DGEBF21 5 Sensitizer 6.5 12 23 
PGE21 56 Sensitizer 16 63 182 
1 76 Sensitizer 5.7 19 69 
2 2.2b Non-sensitizer 9.9b No value 31 
3 120 Sensitizer 13 16 38 
4 1.2 Non-sensitizer No value No value > 2000 
5 209 Sensitizer 60 105 284 
6 43 Sensitizer 37 73 169 
a KeratinoSens™ assay performed using KeratinoSens™ reporter keratinocytes, which contain a stable insertion of a 
luciferase gene under control of the ARE element of the AKR1C2 gene. Imax is defined as the average maximal 
induction of gene activity. A luciferase induction of greater than 1.5-fold at non-cytotoxic concentrations was 
considered to be significant for skin sensitization. All assays were performed in triplicate on at least 3 separate 
occasions. 
b Fold-induction of > 1.5 was only noted at cytotoxic concentrations; therefore this compound is classified as a non-
sensitizer according to the KeratinoSens™  
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[M* + H]+ 
m/z 










DGEBF 312.4 1125.4 563.3 986.4 849.3 434.2 306.2 
1 314.4 1127.4 564.2 988.3 851.4 434.2 306.2 
PGE 150.2 963.3 482.2 824.2 687.2 434.2 Ndb 
aM* or y* indicates haptenated peptide or peptide fragment, respectively; y indicates unhaptenated peptide 
fragment. The mass of the unhaptenated peptide (M) is 813.2. The masses of the unhaptenated fragments are as 
follows: y2: 306.2; y3: 434.2; y4: 537.3; y5: 674.3 





Figure 1. Structures of DGEBA (diglycidyl ether of bisphenol A), DGEBF (diglycidyl ether of 
bisphenol F), PGE (phenyl glycidyl ether) and analogues 
Figure 2. Local Lymph Node Assay (LLNA) results for DGEBF, 1 and 2. The EC3 value (estimated 
concentration required to induce a stimulation index (SI) of 3) was calculated using linear interpolation. 
EC3 values are as follows: DGEBF: 0.036 M (1.1 % w/v);21 1: 0.074 M (2.3 % w/v); 2 > 0.95 M (> 30 
% w/v). 
Figure 3. Peptide depletion by DGEBF, 1 and PGE. The model peptide AcPHCKRM was incubated 
with the relevant compound (1: 10) in a mixture of 1:1 DMSO: potassium phosphate buffer (100 mM, 










































































Scheme 1. Synthesis of compounds 1, 2 and 4a 
*TBDMS=tert-butyldimethylsilyl 
aReagents and conditions: A. (i) KOH, EtOH, N2, 24 h, reflux; (ii) 4-Methylmorpholine, THF, -20 ˚C (30 min), N2, 
triethylamine, DMF, 0 ˚C (3.5 h); (iii) C4H9Li, THF, N2, -78 ˚C; (iv) ZnI2, NaBH3CN, ClCH2CH2Cl, 20 h, rt; (v) 
TBAF, THF, N2, 3 h, rt; (vi) Cs2CO3, CH3CN, N2, 3 h, reflux. B & C. KOH, EtOH, N2, 4 h, reflux. 
Scheme 2. Synthesis of compounds 5 and 6a 
aReagents and conditions: (i) NaH, THF, N2, reflux, overnight; (ii) CHCl3, 0 ˚C then RT until complete on TLC 
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